Annual FCF
-$69.11 M
+$8.48 M+10.93%
December 31, 2023
Summary
- As of March 4, 2025, XLO annual free cash flow is -$69.11 million, with the most recent change of +$8.48 million (+10.93%) on December 31, 2023.
- During the last 3 years, XLO annual FCF has fallen by -$30.83 million (-80.53%).
- XLO annual FCF is now -272.38% below its all-time high of -$18.56 million, reached on December 31, 2019.
Performance
XLO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$13.68 M
-$33.61 M-168.64%
September 30, 2024
Summary
- As of March 4, 2025, XLO quarterly free cash flow is -$13.68 million, with the most recent change of -$33.61 million (-168.64%) on September 30, 2024.
- Over the past year, XLO quarterly FCF has stayed the same.
- XLO quarterly FCF is now -168.64% below its all-time high of $19.93 million, reached on June 30, 2024.
Performance
XLO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$17.68 M
-$312.00 K-1.80%
September 30, 2024
Summary
- As of March 4, 2025, XLO TTM free cash flow is -$17.68 million, with the most recent change of -$312.00 thousand (-1.80%) on September 30, 2024.
- Over the past year, XLO TTM FCF has stayed the same.
- XLO TTM FCF is now -1.80% below its all-time high of -$17.37 million, reached on June 30, 2024.
Performance
XLO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
XLO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.9% | 0.0% | 0.0% |
| 3 y3 years | -80.5% | 0.0% | 0.0% |
| 5 y5 years | - | 0.0% | 0.0% |
XLO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +15.6% | -168.6% | +46.2% | -1.8% | +78.4% |
| 5 y | 5-year | -272.4% | +15.6% | -168.6% | +46.2% | -1.8% | +78.4% |
| alltime | all time | -272.4% | +15.6% | -168.6% | +46.2% | -1.8% | +78.4% |
Xilio Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.68 M(-168.6%) | -$17.68 M(+1.8%) |
| Jun 2024 | - | $19.93 M(-289.8%) | -$17.37 M(-68.0%) |
| Mar 2024 | - | -$10.50 M(-21.8%) | -$54.19 M(-21.6%) |
| Dec 2023 | -$69.11 M(-10.9%) | -$13.43 M(+0.4%) | -$69.11 M(-7.1%) |
| Sep 2023 | - | -$13.37 M(-20.8%) | -$74.41 M(-8.5%) |
| Jun 2023 | - | -$16.89 M(-33.6%) | -$81.28 M(-0.8%) |
| Mar 2023 | - | -$25.42 M(+35.7%) | -$81.92 M(+5.6%) |
| Dec 2022 | -$77.59 M | -$18.73 M(-7.5%) | -$77.59 M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$20.24 M(+15.5%) | -$76.40 M(-0.8%) |
| Jun 2022 | - | -$17.53 M(-16.9%) | -$76.99 M(-3.8%) |
| Mar 2022 | - | -$21.09 M(+20.2%) | -$80.04 M(-2.2%) |
| Dec 2021 | -$81.85 M(+113.8%) | -$17.54 M(-15.8%) | -$81.85 M(+27.3%) |
| Sep 2021 | - | -$20.83 M(+1.3%) | -$64.31 M(+47.9%) |
| Jun 2021 | - | -$20.57 M(-10.2%) | -$43.48 M(+89.8%) |
| Mar 2021 | - | -$22.90 M | -$22.90 M |
| Dec 2020 | -$38.28 M(+106.3%) | - | - |
| Dec 2019 | -$18.56 M | - | - |
FAQ
- What is Xilio Therapeutics annual free cash flow?
- What is the all time high annual FCF for Xilio Therapeutics?
- What is Xilio Therapeutics annual FCF year-on-year change?
- What is Xilio Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly FCF year-on-year change?
- What is Xilio Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Xilio Therapeutics?
- What is Xilio Therapeutics TTM FCF year-on-year change?
What is Xilio Therapeutics annual free cash flow?
The current annual FCF of XLO is -$69.11 M
What is the all time high annual FCF for Xilio Therapeutics?
Xilio Therapeutics all-time high annual free cash flow is -$18.56 M
What is Xilio Therapeutics annual FCF year-on-year change?
Over the past year, XLO annual free cash flow has changed by +$8.48 M (+10.93%)
What is Xilio Therapeutics quarterly free cash flow?
The current quarterly FCF of XLO is -$13.68 M
What is the all time high quarterly FCF for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly free cash flow is $19.93 M
What is Xilio Therapeutics quarterly FCF year-on-year change?
Over the past year, XLO quarterly free cash flow has changed by $0.00 (0.00%)
What is Xilio Therapeutics TTM free cash flow?
The current TTM FCF of XLO is -$17.68 M
What is the all time high TTM FCF for Xilio Therapeutics?
Xilio Therapeutics all-time high TTM free cash flow is -$17.37 M
What is Xilio Therapeutics TTM FCF year-on-year change?
Over the past year, XLO TTM free cash flow has changed by $0.00 (0.00%)